Professor Lyn Griffiths
Executive Director, Institute of Health and Biomedical Innovation, Queensland University of Technology, Australia
Dr. Griffiths has tested a quicker, more cost-effective genetic identification methodology, called Next Generation Sequencing(NGS). The utilization of the NGS methodology has proven successful in identifying individuals with the FHM mutation, and has proven to be 100% consistent with the older (Sanger) methodology. The results of this research should allow more available and faster genetic testing of headache patients. Her research has garnered attention of several medical groups, including the Mayo Clinic.
Comments are closed.